The ROE (Return on Equity) of ALX Oncology Holdings Inc (ALXO) is -84.76%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2023-12-31 | -84.76% |
| 2022-12-31 | -46.86% |
| 2021-12-31 | -22.99% |
| 2020-12-31 | -10.64% |
| 2019-12-31 | 6413.33% |
| 2018-12-31 | -149.24% |